insights_auto
Hvorfor har GH gått opp? 2,50%?
Gå mer i dybdenchevron_right
GH:NASDAQ
Guardant Health Inc
166,66 USD
arrow_upward
+2,50%(+4,07) 1 D
166,66 USD
0,00% (0,00)
bedtimeEtter stengetid
Stengt: 21. okt., 16:00:01 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for GH …
Åpne
162,29 USD
Høy
171,22 USD
Lav
162,00 USD
Markedsverdi
22,37 mrd.
Snittvolum
1,78 mill.
Volum
2,54 mill.
52 u høy
191,01 USD
52 u lav
66,59 USD
EPS
−3,50 USD
Beta
1,58
Utestående aksjer
134,20 mill.
Antall ansatte
2k
Åpne
162,29 USD
Høy
171,22 USD
Lav
162,00 USD
Markedsverdi
22,37 mrd.
Snittvolum
1,78 mill.
Volum
2,54 mill.
52 u høy
191,01 USD
52 u lav
66,59 USD
EPS
−3,50 USD
Beta
1,58
Utestående aksjer
134,20 mill.
Antall ansatte
2k
Nyhetssaker
Fra nettkilder og nyhetspartnere
News Corp
·
for 1 time siden
7 healthcare stocks that stand out as investors pay up for the sector
Zacks
·
for 8 timer siden
Natera Partners With TransCode to Advance Colorectal Cancer Trial
Stock Titan
·
for 1 døgn siden
Five short talks will explore blood-based cancer tests at ESMO, among 25 studies from Guardant and collaborators.
MarketBeat
·
for 2 døgn siden
The AI Trade Just Moved Into Your Bloodstream, and 4 Healthcare Stocks Are Winning
Profil
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
Om Guardant Health Inc
Administrerende direktørHelmy Eltoukhy | AmirAli Talasaz
Ansatte2,5k
Grunnlagt2012
HovedkontorPalo Alto, California, USA
Sektor-
Nettstedguardanthealth.com